Australia markets close in 2 hours 47 minutes

EDIT May 2024 7.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
2.6500+0.4700 (+21.56%)
As of 03:26PM EDT. Market open.
Full screen
Previous close2.1800
Open2.6000
Bid2.2500
Ask3.8000
Strike7.50
Expiry date2024-05-17
Day's range2.6000 - 2.6500
Contract rangeN/A
Volume27
Open interest513
  • Thomson Reuters StreetEvents

    Q1 2024 Editas Medicine Inc Earnings Call

    Q1 2024 Editas Medicine Inc Earnings Call

  • Zacks

    Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates

    Editas (EDIT) delivered earnings and revenue surprises of -20.63% and 90.26%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Editas Medicine Announces First Quarter 2024 Results and Business Updates

    Completed adult cohort enrollment and enrolled multiple patients in the adolescent cohort of the Phase 1/2/3 RUBY clinical trial of reni-cel for severe sickle cell disease On track to present additional clinical data from the RUBY trial and the EdiTHAL trial of reni-cel for transfusion-dependent beta-thalassemia in mid-2024 and additional updates by year-end 2024 Presenting pre-clinical data at ASGCT on in vivo capabilities to support development of transformative in vivo gene editing medicines